Phase 1 Study of HSP90 Inhibitor Ganetespib with Pemetrexed and Cisplatin/Carboplatin Chemotherapy for Pleural Mesothelioma

被引：2
|
作者：
Fennell, D. [1 ]
Danson, S. [2 ]
Forster, M. [3 ]
Talbot, D. [4 ]
Woll, P. [5 ]
Child, J. [6 ]
Ngai, Y. [6 ]
Farrelly, L. [6 ]
Hackshaw, A. [6 ]
Sharkey, A. [1 ]
Busacca, S. [1 ]
Hastings, R. [1 ]
Barnes, D. [7 ]
Nicolson, M. [8 ]
Taylor, P. [9 ]
Ahmed, S. [7 ]
Wheeler, G. [6 ]
机构：
[1] Univ Leicester, Leicester, Leics, England
[2] Univ Sheffield, Sheffield Ecmc, Sheffield, S Yorkshire, England
[3] Univ Coll London Hosp, CRUK Luncer Canc Ctr Excellence, London, England
[4] Univ Oxford, Dept Oncol, Oxford, England
[5] Univ Sheffield, Weston Pk Hosp, Dept Oncol, Sheffield, S Yorkshire, England
[6] UCL, Canc Res UK & UCL Canc Trials Ctr, London, England
[7] Univ Hosp Leicester NHS Trust, Leicester, Leics, England
[8] Aberdeen Royal Infirm, Aberdeen, Scotland
[9] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Manchester, Lancs, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
HSP90; inhibition; Dose-escalation; Pleural mesothelioma;
D O I：
10.1016/j.jtho.2018.08.415
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA12.05
引用
收藏
页码：S397 / S397
页数：1
相关论文
共 50 条
  • [21] Pemetrexed plus Carboplatin or Cisplatin as Neoadjuvant Treatment of Operable Malignant Pleural Mesothelioma (MPM)
    Pasello, Giulia
    Marulli, Giuseppe
    Polo, Valentina
    Breda, Cristiano
    Bonanno, Laura
    Loreggian, Lucio
    Rea, Federico
    Favaretto, Adolfo
    ANTICANCER RESEARCH, 2012, 32 (12) : 5393 - 5399
  • [22] Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
    Vogelzang, NJ
    Rusthoven, JJ
    Symanowski, J
    Denham, C
    Kaukel, E
    Ruffie, P
    Gatzemeier, U
    Boyer, M
    Emri, S
    Manegold, C
    Niyikiza, C
    Paoletti, P
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) : 2636 - 2644
  • [23] Malignant pleural mesothelioma treated with pemetrexed and cisplatin: a therapy study
    Davis, L.
    LUNG CANCER, 2013, 79 : S32 - S33
  • [24] Combination Chemotherapy with Cisplatin, Pemetrexed, and Nivolumab for Malignant Pleural Mesothelioma: A Trial in Progress
    Fujimoto, N.
    Aoe, K.
    Kozuki, T.
    Oze, I.
    Kato, K.
    Kishimoto, T.
    Hotta, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S746 - S746
  • [25] Radiation Recall Dermatitis after Pemetrexed Cisplatin chemotherapy in malignant pleural mesothelioma
    Berdel, C.
    Ruebe, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 : 7 - 7
  • [26] Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
    Skopljanac, Ivan
    Segrt, Ivana
    Mise, Kornelija
    Vukovac, Emilija Lozo
    Biocina, Anita Tolic
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [27] Evaluating the HSP90 Inhibitor Ganetespib as a Radiosensitizing Agent in Breast Cancer Models In Vitro
    Corso, C.
    Ginsburg, J.
    Wen, J.
    Willard, M.
    Diaz, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S699 - S700
  • [28] Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancers
    Gutierrez, Martin
    Guo, Robin
    Giaccone, Giuseppe
    Liu, Stephen V.
    Hao, Zhonglin
    Hilton, Christie
    Hinson, James M., Jr.
    Kris, Mark G.
    Orlemans, Everardus Otto
    Drilon, Alexander
    LUNG CANCER, 2021, 162 : 23 - 28
  • [29] A Pathological Complete Response in Malignant Pleural Mesothelioma after Combination Chemotherapy with Carboplatin and Pemetrexed
    Kao, Steven Chuan-Hao
    McCaughan, Brian
    Muljono, Anita
    Boyer, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (03) : 405 - 406
  • [30] Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans
    Yuan, Rui
    Tu, Jie
    Sheng, Chunquan
    Chen, Xi
    Liu, Na
    FRONTIERS IN MICROBIOLOGY, 2021, 12
12345